Bio-Techne TECH Protein Sciences — Selling General And Administrative Expense

Other segment segments

Similar metrics at other companies

ALife Sciences and Diagnostics Markets — Selling, General and Administrative Expense

$170M+8.3%

STELife Sciences: — Selling, general, and administrative

$15.6M+4.0%

STELife Science Member — Selling, general, and administrative

$16M+8.1%

BIIBReportable Segment — SG&A

$608.4M+1.2%

TSNCorporate and Other — Segment Selling, General and Administrative

$39.75M-25.4%

GMEDMusculoskeletal Solutions And Enabling Technologies — Other Selling General And Administrative Expense

$55.53M+25.5%

Questions, answered.

What is Bio-Techne's protein sciences — selling general and administrative expense?

Bio-Techne (TECH) reported protein sciences — selling general and administrative expense of $57.91M in Q1 2026.

How has Bio-Techne's protein sciences — selling general and administrative expense changed year-over-year?

Bio-Techne's protein sciences — selling general and administrative expense increased by 3.8% year-over-year, from $55.8M to $57.91M.

What is the long-term trend for Bio-Techne's protein sciences — selling general and administrative expense?

Over 2 years (2023 to 2025), Bio-Techne's protein sciences — selling general and administrative expense has grown at a 5.8% compound annual growth rate (CAGR), from $204.48M to $229.06M.

What does protein sciences — selling general and administrative expense mean?

The overhead and operating costs required to run the sales and administrative functions of the Protein Sciences segment.

How do you interpret protein sciences — selling general and administrative expense?

Rising expenses relative to revenue may indicate increased investment in growth or potential inefficiencies in administrative scaling.

How does protein sciences — selling general and administrative expense compare across companies?

Standard 'SG&A' expense; peers typically report this as a core operating expense line item.